Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres.
Esther H L ChanDunnya De-SilvaAdeline H F LinNeil RabinAshutosh WechalekarRakesh PopatWee Joo ChngKwee L YongPublished in: British journal of haematology (2018)